Business
Glenmark Pharmaceuticals Limited Press Release Jun 17 2026
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 17, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial".
About this update from Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 17, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial". View Attachment
View stock analysis, news, and events for Glenmark Pharmaceuticals Limited